Cargando…
Screening a Broad Range of Solid and Haematological Tumour Types for CD70 Expression Using a Uniform IHC Methodology as Potential Patient Stratification Method
The constitutive expression of CD70 has been described in various haematological and solid tumour types. In addition, the co-expression of its receptor in tumours has been demonstrated, mediating tumour cell proliferation. Although CD70 expression is a prerequisite to enrol patients in solid tumour...
Autores principales: | Flieswasser, Tal, Camara-Clayette, Valérie, Danu, Alina, Bosq, Jacques, Ribrag, Vincent, Zabrocki, Piotr, Van Rompaey, Luc, de Haard, Hans, Zwaenepoel, Karen, Smits, Evelien, Pauwels, Patrick, Jacobs, Julie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826714/ https://www.ncbi.nlm.nih.gov/pubmed/31652572 http://dx.doi.org/10.3390/cancers11101611 |
Ejemplares similares
-
The CD70-CD27 axis in oncology: the new kids on the block
por: Flieswasser, Tal, et al.
Publicado: (2022) -
Site-specific (68)Ga-labeled nanobody for PET imaging of CD70 expression in preclinical tumor models
por: Dewulf, Jonatan, et al.
Publicado: (2023) -
BMP7 Expression Correlates with Secondary Drug Resistance in Mantle Cell Lymphoma
por: Camara-Clayette, Valérie, et al.
Publicado: (2013) -
Preclinical data on the combination of cisplatin and anti-CD70 therapy in non-small cell lung cancer as an excellent match in the era of combination therapy
por: Jacobs, Julie, et al.
Publicado: (2017) -
Targeting CD70 in combination with chemotherapy to enhance the anti-tumor immune effects in non-small cell lung cancer
por: Flieswasser, Tal, et al.
Publicado: (2023)